Trends in Cardiovascular Medicine
Volume 15, Issue 4 , Pages 125-129 , May 2005

Transcriptional Regulation at the Chromatin Level in the Cardiovasculature Through Protein-protein Interactions and Chemical Modifications

  • Toru Suzuki

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Toru Suzuki, MD, PhD, Department of Cardiovascular Medicine, Department of Clinical Bioinformatics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Tel.: (+81) 3-3815-5411 ext. 33117; fax: (+81) 3-5800-8824.
    • ,
  • Takayoshi Matsumura
    • ,
  • Ryozo Nagai

References 

  1. Adachi Y, Pavlakis GN, Copeland TD. Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation break point in acute undifferentiated leukemia. J Biol Chem. 1994;269:2258–2262
  2. Aizawa K, Suzuki T, Kada N, et al. Regulation of platelet-derived growth factor-A chain by Kruppel-like factor 5: New pathway of cooperative activation with nuclear factor-kappaB. J Biol Chem. 2004;279:70–76
  3. Akey CW, Luger K. Histone chaperones and nucleosome assembly. Curr Opin Struct Biol. 2003;13:6–14
  4. Bieker JJ. Kruppel-like factors: Three fingers in many pies. J Biol Chem. 2001;276:34355–34358
  5. Black AR, Black JD, Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol. 2001;188:143–160
  6. Bouwman P, Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol. 2002;195:27–38
  7. Cao D, Wang Z, Zhang CL, et al. Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol Cell Biol. 2005;25:364–376
  8. Chang S, McKinsey TA, Zhang CL, et al. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol. 2004;24:8467–8476
  9. Dai YS, Markham BE. p300 Functions as a coactivator of transcription factor GATA-4. J Biol Chem. 2001;276:37178–37185
  10. Dang DT, Pevsner J, Yang VW. The biology of the mammalian Kruppel-like family of transcription factors. Int J Biochem Cell Biol. 2000;32:1103–1121
  11. De la Serna IL, Carlson KA, Imbalzano AN. Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. Nat Genet. 2001;27:187–190
  12. Doetzlhofer A, Rotheneder H, Lagger G, et al. Histone deacetylase 1 can repress transcription by binding to Sp1. Mol Cell Biol. 1999;19:5504–5511
  13. Dynan WS, Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell. 1983;35:79–87
  14. Feinberg MW, Lin Z, Fisch S, et al. An emerging role for Kruppel-like factors in vascular biology. Trends Cardiovasc Med. 2004;14:241–246
  15. Gamble MJ, Erdjument-Bromage H, Tempst P, et al. The histone chaperone TAF-I/SET/INHAT is required for transcription in vitro of chromatin templates. Mol Cell Biol. 2005;25:797–807
  16. Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 1997;90:595–606
  17. Gusterson R, Brar B, Faulkes D, et al. The transcriptional co-activators CBP and p300 are activated via phenylephrine through the p42/p44 MAPK cascade. J Biol Chem. 2002;277:2517–2524
  18. Han J, Molkentin JD. Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends Cardiovasc Med. 2000;10:19–22
  19. Haushalter KA, Kadonaga JT. Chromatin assembly by DNA-translocating motors. Nat Rev Mol Cell Biol. 2003;4:613–620
  20. Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293:1074–1080
  21. Juan LJ, Shia WJ, Chen MH, et al. Histone deacetylases specifically down-regulate p53-dependent gene activation. J Biol Chem. 2000;275:20436–20443
  22. Kaczynski J, Cook T, Urrutia R. Sp1- and Kruppel-like transcription factors. Genome Biol. 2003;4:206
  23. Kadam S, McAlpine GS, Phelan ML, et al. Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev. 2000;14:2441–2451
  24. Khorasanizadeh S. The nucleosome: From genomic organization to genomic regulation. Cell. 2004;116:259–272
  25. Kolodziejczyk SM, Wang L, Balazsi K, et al. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr Biol. 1999;9:1203–1206
  26. Kornberg RD. Eukaryotic transcriptional control. Trends Cell Biol. 1999;9:M46–M49
  27. Kornberg RD, Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell. 1999;98:285–294
  28. Kurdistani SK, Grunstein M. Histone acetylation and deacetylation in yeast. Nat Rev Mol Cell Biol. 2003;4:276–284
  29. Lassar AB, Paterson BM, Weintraub H. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell. 1986;47:649–656
  30. Liang Q, De Windt LJ, Witt SA, et al. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem. 2001;276:30245–30253
  31. Lin Q, Schwarz J, Bucana C, et al. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science. 1997;276:1404–1407
  32. Loven MA, Muster N, Yates JR, et al. A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation. Mol Endocrinol. 2003;17:67–78
  33. Mal A, Sturniolo M, Schiltz RL, et al. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: Inhibition of the myogenic program. EMBO J. 2001;20:1739–1753
  34. Masumi A, Wang IM, Lefebvre B, et al. The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness. Mol Cell Biol. 1999;19:1810–1820
  35. Matsumoto K, Nagata K, Okuwaki M, et al. Histone- and chromatin-binding activity of template activating factor-I. FEBS Lett. 1999;463:285–288
  36. Matsumura T, Suzuki T, Aizawa K, et al. The deacetylase HDAC1 negatively regulates the cardiovascular transcription factor Kruppel-like factor 5 through direct interaction. J Biol Chem. 2005;280:12123–12129
  37. McKinsey TA, Zhang CL, Olson EN. Control of muscle development by dueling HATs and HDACs. Curr Opin Genet Dev. 2001;11:497–504
  38. McKinsey TA, Zhang CL, Olson EN. Signaling chromatin to make muscle. Curr Opin Cell Biol. 2002;14:763–772
  39. Miyamoto S, Suzuki T, Muto S, et al. Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain. Mol Cell Biol. 2003;23:8528–8541
  40. Molkentin JD. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem. 2000;275:38949–38952
  41. Nagata K, Kawase H, Handa H, et al. Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis. Proc Natl Acad Sci USA. 1995;92:4279–4283
  42. Nakatani Y. Histone acetylases-versatile players. Genes Cells. 2001;6:79–86
  43. Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell. 2002;108:475–487
  44. Okuwaki M, Nagata K. Template activating factor-I remodels the chromatin structure and stimulates transcription from the chromatin template. J Biol Chem. 1998;273:34511–34518
  45. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767–801
  46. Patient RK, McGhee JD. The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev. 2002;12:416–422
  47. Philipsen S, Suske G. A tale of three fingers: The family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 1999;27:2991–3000
  48. Puri PL, Iezzi S, Stiegler P, et al. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol Cell. 2001;8:885–897
  49. Puri PL, Sartorelli V, Yang XJ, et al. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell. 1997;1:35–45
  50. Rice JC, Allis CD. Code of silence. Nature. 2001;414:258–261
  51. Sartorelli V, Huang J, Hamamori Y, et al. Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol. 1997;17:1010–1026
  52. Sartorelli V, Puri PL, Hamamori Y, et al. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol Cell. 1999;4:725–734
  53. Seo SB, McNamara P, Heo S, et al. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell. 2001;104:119–130
  54. Shindo T, Manabe I, Fukushima Y, et al. Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med. 2002;8:856–863
  55. Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403:41–45
  56. Sun R, Chen X, Yang VW. Intestinal-enriched Kruppel-like factor (Kruppel-like factor 5) is a positive regulator of cellular proliferation. J Biol Chem. 2001;276:6897–6900
  57. Suzuki T, Horikoshi M, Nagai R. Regulation of the Sp/KLF-family of transcription factors: focus on post-transcriptional modification and protein-protein interaction in the context of chromatin. Gene Ther Mol Biol. 2003;7:91–97
  58. Suzuki T, Kimura A, Nagai R, et al. Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding. Genes Cells. 2000;5:29–41
  59. Suzuki T, Muto S, Miyamoto S, et al. Functional interaction of the DNA-binding transcription factor Sp1 through its DNA-binding domain with the histone chaperone TAF-I. J Biol Chem. 2003;278:28758–28764
  60. Suzuki T, Nagai R, Yazaki Y. Mechanisms of transcriptional regulation of gene expression in smooth muscle cells. Circ Res. 1998;82:1238–1242
  61. Suzuki T, Yamamoto T, Kurabayashi M, et al. Isolation and initial characterization of GBF, a novel DNA-binding zinc finger protein that binds to the GC-rich binding sites of the HIV-1 promoter. J Biochem (Tokyo). 1998;124:389–395
  62. Turner J, Crossley M. Mammalian Krüppel-like transcription factors: More than just a pretty finger. Trends Biochem Sci. 1999;24:236–240
  63. Wang DZ, Olson EN. Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr Opin Genet Dev. 2004;14:558–566
  64. Wang Z, Wang DZ, Pipes GC, et al. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci USA. 2003;100:7129–7134
  65. Watanabe N, Kurabayashi M, Shimomura Y, et al. BTEB2, a Kruppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. Circ Res. 1999;85:182–191
  66. Yao YL, Yang WM, Seto E. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol. 2001;21:5979–5991
  67. Zhang CL, McKinsey TA, Chang S, et al. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell. 2002;110:479–488
  68. Zhang W, Bieker JJ. Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc Natl Acad Sci USA. 1998;95:9855–9860

PII: S1050-1738(05)00030-7

doi: 10.1016/j.tcm.2005.04.003

Trends in Cardiovascular Medicine
Volume 15, Issue 4 , Pages 125-129 , May 2005

Article Tools

* Image Usage & Resolution